COV504Homo sapiens (Human)Cancer cell line

Also known as: COV 504, Cov504

🤖 AI SummaryBased on 8 publications

Quick Overview

COV504 is a human ovarian cancer cell line derived from a serous carcinoma, used in cancer research.

Detailed Summary

COV504 is a human ovarian cancer cell line derived from a serous carcinoma, commonly used in cancer research. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been analyzed for genomic and transcriptomic profiles. COV504 exhibits specific genetic and molecular characteristics that make it a valuable model for studying high-grade serous ovarian cancer (HGSOC). Research on COV504 has contributed to understanding the genomic similarities between cell lines and primary tumors, highlighting its utility in preclinical studies. The cell line has been utilized in studies examining drug sensitivity, gene expression, and molecular profiling, providing insights into cancer biology and therapeutic strategies.

Research Applications

Genomic profilingTranscriptomic analysisDrug sensitivity testingMolecular profiling

Key Characteristics

High-grade serous ovarian cancer modelPart of the Cancer Cell Line Encyclopedia (CCLE)Used in studies on genomic and transcriptomic profilesRelevant for preclinical cancer research
Generated on 6/18/2025

Basic Information

Database IDCVCL_2424
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age CategoryUnknown
SexFemale

Disease Information

DiseaseOvarian carcinoma
LineageOvary/Fallopian Tube
SubtypeSerous Ovarian Cancer
OncoTree CodeSOC

DepMap Information

Source TypeECACC
Source IDACH-001048_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Leu323fs (c.966_967delAC)Unspecified-Unknown, PubMed=28273451, PubMed=25230021

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12,13
D13S317
9,11
D16S539
9,11
D18S51
13
D19S433
15
D21S11
29
D2S1338
17,19
D3S1358
16
D5S818
11
D7S820
10,12
D8S1179
12,13
FGA
22
Penta D
13
Penta E
7,16
TH01
6,7
TPOX
8,9
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Interrogation of functional cell-surface markers identifies CD151 dependency in high-grade serous ovarian cancer.

Drapkin R.I., Ailles L., Mes-Masson A.-M., Rottapel R.

Cell Rep. 18:2343-2358(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.

Helleman J.

PLoS ONE 9:E103988-E103988(2014).

Evaluating cell lines as tumour models by comparison of genomic profiles.

Domcke S., Sinha R., Levine D.A., Sander C., Schultz N.

Nat. Commun. 4:2126.1-2126.10(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics.

Cornelisse C.J., Schrier P.I.

Int. J. Cancer 53:613-620(1993).